Compare Mercadolibre Inc (MELI) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mercadolibre Inc vs NeoGenomics Inc. Common Stock — how do they compare? Mercadolibre Inc trades at $1,825.09 (market cap $93.24B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: Mercadolibre Inc is far larger — about 43× NeoGenomics Inc. Common Stock's market cap, and Mercadolibre Inc is trading nearer its 52-week high, NeoGenomics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mercadolibre Inc for 118 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MELI | NEO | |
|---|---|---|
Market Cap | $93.24B | $2.17B |
Volume | 380,071 | 1,615,943 |
Sector | Consumer Cyclical | Health |
52-Week High | $2.36K | $19.91 |
52-Week Low | $1.55K | $7.19 |
Typical Hold Time | 118 Days | 0 Days |
Enterprise Value | $100.88B | $2.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MercadoLibre (MELI) trades at $1,876.04, down 0.87% on the day, with strong technical bullish signals from moving averages. The company demonstrates robust revenue growth, reaching $28.89 billion in 2025, though net income margin declined to 6.91%. Recent news highlights expansion in Brazil with one-hour delivery services and growing fintech credit portfolio, while analyst consensus remains strongly bullish with a $2,160 price target.
MELI presents a compelling growth story in Latin American e-commerce and fintech, supported by expanding market share and ecosystem integration. Key risks include macroeconomic pressures in Argentina and margin compression despite revenue growth. With 73% analyst buy ratings and institutional accumulation, the stock offers upside potential but requires monitoring of profitability trends and regional economic stability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
